Autonomous Medical Devices
SKC develops proprietary, flexible microbiosensors for diverse industries, enabling low-cost, portable disease detection.
Founded
2013SKC develops proprietary, flexible microbiosensors for diverse industries, enabling low-cost, portable disease detection.
Autonomous Medical Devices (AMDI), originally known as Sensor-Kinesis Corp. (SKC), was founded with the mission to revolutionize point-of-care testing through advanced microfluidics and protein engineering. The company specializes in developing proprietary, flexible microbiosensors that can detect and measure biological signals from humans. These sensors are designed for integration with smart devices, allowing for real-time data transmission and analysis via cloud technology. AMDI's products target diverse industries, including healthcare and molecular diagnostics, aiming to provide low-cost, portable disease detection solutions.
Notable affiliated individuals include experts in microfluidics and protein engineering, although specific names are not provided. AMDI has garnered significant attention and funding, including a $5.3 million NIH RAD® Tech Award to finalize their innovative technologies. The company's key achievements include developing next-generation point-of-care testing solutions that eliminate sample preparation delays. Overall, AMDI's impact lies in its potential to transform disease detection and diagnostics, making healthcare more accessible and efficient.
Companies similar to Autonomous Medical Devices include Novel Microdevices, Amydis, Advanced Medical Device Technologies and Neuro-Kinesis.
Autonomous Medical Devices was founded in 2013.
Autonomous Medical Devices' headquarters is located in Los Angeles, CA, US.
Autonomous Medical Devices' most recent funding round was for $1.2M (USD) in April 2023.
As of Apr 12, 2023, Autonomous Medical Devices has raised a total of $142.7M (USD).
Autonomous Medical Devices has 55 employees as of Feb 5, 2024.
Advanced Medical Device Technologies
advancedmdt.com
